# A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers

> **NCT01436565** · PHASE1 · COMPLETED · sponsor: **Sanofi** · enrollment: 26 (actual)

## Conditions studied

- Solid Tumor Cancers

## Interventions

- **DRUG:** MM-121 (SAR256212)
- **DRUG:** SAR245408

## Key facts

- **NCT ID:** NCT01436565
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01436565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01436565, "A Study of Investigational SAR256212 in Combination With SAR245408 in Patients With Solid Tumor Cancers". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01436565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*